High antibody titers of anti–citrullinated peptide antibodies, rheumatoid factor, and certain baseline factors predict RA ...

Phase I trial results show the potential of once-yearly lenacapavir as a long-acting PrEP option for HIV, supporting further ...

For more information on the Phase 1b clinical trial, visit: https://clinicaltrials.gov/study/NCT06732180 ...

Pheiron and Ribo are excited to announce that the first two strategic collaboration milestones have been successfully ...

This year’s conference highlighted a number of critical areas in clinical R&D including financial management, representation, ...

Optimal therapeutic targeting of cancer involves clonal signals which are expressed within all cancer cellsGradalis applies a novel clinically relevant approach to determine clonal tumor mutation ...

MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA), a clinical-stage pharmaceutical company focused on developing therapies for neurological and neuropsychiatric disorders, today announced the successful ...

Effective drug discovery and development hinge on high-quality data. Implementing FAIR principles enhances data usability and ...

Genmab has stopped clinical development of a blood cancer treatment after Johnson & Johnson decided it won't exercise its option to license it.

Medical has completed the integration and design enhancements of the Apex 6 Generator into a fully integrated transvascular ...

Jonathon Whitton, AuD, PhD, VP, auditory global program head, Regeneron, discusses how key regulatory designations, such as ...

Johns Hopkins University said it would eliminate more than 2,000 jobs after President Donald Trump’s administration rescinded ...